YYAI YYAI
Company Profile ↓Company Overview
YYAI (YYAI) is a publicly traded company listed on with a market capitalization of $5.17K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 24.9%.
Net profit has compounded at 134.7% per year over the last five years.
Revenue has grown at a 133.1% CAGR over the past five years.
Maintains a net profit margin of 27.2%.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Apr 2025 Revenue of $12.82M (+146.7% YoY); net profit $3.49M.
- Trailing 12 Months Year-on-year growth — revenue +146.7%, earnings +33.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 133.1%, profit CAGR 134.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 133.11% |
| 1 Year: | 146.70% |
Compounded Profit Growth
| 5 Years: | 134.70% |
| 1 Year: | 32.97% |
Stock Price Performance
| 1 Year: | -100.00% |
| 6 Months: | -99.91% |
| 3 Months: | -99.59% |
| 1 Month: | -37.37% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)26.47 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 24.9%.
- Excellent profit margin of 27.2%.
- Compounding revenue at 133.1% over 5 years.
- Profit CAGR of 134.7% over 5 years.
CONS
- Trading 100.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jul 2016 | Oct 2016 | Jan 2017 | Jul 2017 | Oct 2017 | Jan 2018 | Jul 2018 | Oct 2018 | Jan 2019 | Jul 2019 | Oct 2019 | Jan 2020 | Jul 2020 | Oct 2020 | Jan 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Jul 2022 | Oct 2022 | Jan 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Jul 2024 | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 564.99K | 2.62M | 4.12M | 2.54M | 5.40M | 4.19M | 3.58M | 2.44M | 1.61M | 3.12M | 2.30M | 480.77K | 3.27M | 3.27M | 3.27M | 3.00M | 3.00M | 3.00M | 6.97M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 744.23K | 744.23K | 744.23K | 744.23K | 6.58M |
| Gross Profit | 0 | 4.80K | 0 | 7.94K | 5.30K | 0 | 0 | 0 | - | - | - | - | -371.92K | 1.04M | 878.15K | 785.22K | 2.08M | 954.81K | 1.02M | 287.04K | 1.07M | 892.75K | 646.96K | 336.54K | 2.53M | 2.53M | 2.53M | 2.26M | 2.26M | 2.26M | 391.31K |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00M | 975.20K | 764.39K | 2.20M | 1.96M |
| Operating Income | -2.02K | 3.30K | -2.12K | -2.47K | 898 | -2.29K | -6.52K | -6.05K | -3.47K | -247.57K | -694.34K | -628.45K | -1.46M | -202.55K | -996.47K | -2.49M | -35.10M | -2.76M | -3.07M | -4.51M | -1.04M | -1.85M | -1.27M | 334.63K | 2.44M | 2.33M | 530.29K | 1.28M | 1.49M | 54.68K | -1.57M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27M | 2.02M | 2.24M | 798.91K | -821.84K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 530.29K | 1.35M | 1.51M | 55.48K | -1.53M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 373.88K | 761.01K | 249.17K | 277.25K | 82.45K |
| Net Income | -2.02K | 3.30K | -2.12K | -2.47K | 864 | -2.29K | -6.52K | -6.05K | -3.47K | -265.07K | -1.45M | -1.35M | -1.37M | -2.52M | -1.29M | -3.44M | -38.83M | -2.37M | -4.27M | -11.02M | -48.88M | -846.76K | 1.76M | 279.42K | -4.22M | -1.37M | -411.21K | 10.39K | 882.65K | 156.50K | -1.62M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.18 | -9.45 | - | -24.29 | -3,881.54 | 147.39 | -1.93 | 0.42 | 0.05 | -1.91 | 6.43 | -56.40 | - | 120.00 | 2.00 | -2.00 |
| R&D Expense | - | - | - | - | - | - | - | - | - | 48.80K | 84.77K | 19.53K | 28.11K | 15.44K | 137.16K | 174.05K | 103.32K | 275.91K | 19.43K | 14.98K | 3.64K | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.70K | 13.24K | 0 | 686.18K | 10.80M | 16.10M | 9.92M | 5.20M | 12.82M |
| Cost of Revenue | - | - | - | - | - | 11.88M | 7.14M | 1.18M | 2.98M |
| Gross Profit | 14.70K | 13.24K | - | -684.72K | 3.12M | 4.22M | 2.78M | 4.02M | 9.84M |
| Operating Expenses | - | - | - | - | - | 50.93M | 24.74M | 164.38K | 3.26M |
| Operating Income | 3.79K | -7.78K | -28.29K | -6.92M | -3.73M | -46.71M | -21.96M | 3.85M | 6.58M |
| EBITDA | - | - | - | - | - | -36.25M | -54.33M | 5.03M | 9.56M |
| Interest Expense | - | - | - | - | - | 10.24M | 5.27M | 2.42M | - |
| Pretax Income | - | - | - | - | - | -46.53M | -71.15M | 3.87M | 6.65M |
| Tax Provision | - | - | - | - | - | 0 | 0 | 1.24M | 2.01M |
| Net Income | 3.79K | -7.78K | -28.29K | -9.23M | -18.59M | -51.77M | -71.15M | 2.63M | 3.49M |
| Diluted EPS | - | - | - | - | - | -25,886,826.00 | -8,894,210.62 | 460.00 | 720.00 |
| R&D Expense | - | - | - | 179.98K | 339.38K | 736.14K | 65.16K | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Jan 2023 | Apr 2023 | Apr 2024 | Apr 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 5.10K | 19.36K | 26.51K | 5.12K | 1.38M | 5.70M | 74.86M | - | 7.11M | 23.16M | 32.91M |
| Current Assets | - | - | - | - | - | - | 12.83M | - | 4.99M | 9.68M | 22.40M |
| Cash & Equivalents | 5.10K | 15.97K | 20.78K | 1.99K | 79.85K | 928.80K | 665.00K | - | 202.09K | 39.35K | 54.74K |
| Inventory | - | - | - | - | - | - | 7.86M | - | 3.19M | 1.61M | - |
| Receivables | - | - | - | - | - | - | 1.03M | - | 399.68K | 4.94M | 15.39M |
| Total Liabilities | 914 | 6.99K | 26.51K | 11.31K | 6.37M | 24.15M | 42.35M | - | 25.72M | 1.44M | 6.49M |
| Current Liabilities | - | - | 3.21K | 11.31K | 4.49M | 24.14M | 38.98M | - | 23.77M | 1.44M | 6.49M |
| Long Term Debt | - | - | - | - | - | - | 2.00M | - | 1.95M | - | - |
| Total Debt | - | - | - | - | - | - | 16.97M | - | 3.44M | 2.73M | - |
| Total Equity | 4.19K | 12.38K | 23.30K | -6.19K | -4.99M | -18.45M | 32.51M | 11.70M | -18.61M | 21.72M | 25.28M |
| Shares Outstanding | - | - | - | - | - | - | 2 | - | 8 | 914 | 7.28K |
Cash Flows (Annual)
Figures in USD.
| Metric | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.27K | -9.09K | -27.79K | -4.21M | -4.52M | -12.37M | -6.37M | 2.49M | -379.38K |
| Investing Cash Flow | -3.00K | -4.80K | 0 | 73.40K | -30.00K | -1.62M | 0 | -16.50M | - |
| Financing Cash Flow | 4.60K | 18.70K | 9.00K | 4.22M | 5.42M | 13.73M | 5.82M | -2.45M | 394.78K |
| Capital Expenditure | 3.00K | - | - | - | - | - | - | - | - |
| Free Cash Flow | 12.27K | - | - | - | - | -12.37M | -6.37M | 2.49M | -379.38K |
| Net Change in Cash | - | - | - | - | - | -250.75K | -544.20K | 39.35K | 15.39K |
| Share Buybacks | - | 0 | 1.20K | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 100.0% | 100.0% | - | -99.8% | 28.9% | 26.2% | 28.0% | 77.3% | 76.8% |
| Operating Margin % | 25.8% | -58.8% | - | -1,008.1% | -34.5% | -290.1% | -221.3% | 74.2% | 51.3% |
| Net Margin % | 25.8% | -58.8% | - | -1,344.8% | -172.1% | -321.5% | -717.1% | 50.5% | 27.2% |
| ROE % | 30.6% | -33.4% | 456.9% | 184.8% | 100.8% | -159.2% | 382.3% | 12.1% | 13.8% |
| ROCE % | - | -33.4% | 456.9% | 222.7% | 20.2% | -130.2% | 131.8% | 17.7% | 24.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0.01% | 508 | $456 |
| 2 | Vanguard Capital Management LLC | 0.01% | 503 | $451 |
| 3 | UBS Group AG | 0.01% | 440 | $395 |
| 4 | Vanguard Fiduciary Trust Co | 0.01% | 238 | $213 |
| 5 | Tower Research Capital LLC (TRC) | - | 19 | $17 |
| 6 | Blackrock Inc. | - | 6 | $5 |
| 7 | Federation Des Caisses Desjardins Du Quebec | - | 2 | $1 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for YYAI
AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K
Smyrna, Delaware, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AiRWA Inc. (NASDAQ: YYAI) (the "Company") today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (…
AiRWA Inc. Announces Completion of Acquisition of Best Life
Smyrna, Delaware, July 30, 2026 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (“AiRWA” or the “Company”) today announced that it has completed its previously announced acquisition of Hong Kong Best Life Trade Co., Limited (“Best Life”), a r…
AiRWA Announces Best Life Acquisition to Diversify Revenue Beyond AI Business
AiRWA (NASDAQ:YYAI) has agreed to acquire import-export company Best Life in a transaction valued at up to $130 million, combining upfront payments with performance-based earn-outs as the company broadens its business portfolio alongside it…
AiRWA Inc. Announces 1-for-40 Reverse Split
Smyrna, Delaware, May 14, 2026 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (the “Company”) announces that, as previously approved by the stockholders of the Company, it will implement a 1-for-40 reverse stock split of its outstanding shar…
AiRWA Inc. Announces 1-for-20 Reverse Split
Smyrna, Delaware, Aug. 13, 2026 (GLOBE NEWSWIRE) -- AiRWA Inc. (Nasdaq: YYAI) (the “Company”) announces that, as previously approved by the stockholders of the Company, it will implement a 1-for-20 reverse stock split of its outstanding sha…
Top Midday Decliners
MapLight Therapeutics' (MPLT) shares tumbled 68% even after the company said its phase 2 trial of ML
YYAI — Frequently Asked Questions
What is the current share price of YYAI?
As of 2026-09-16 18:39 PDT, YYAI trades at $0.71 on NASDAQ/NYSE. Its 52-week range is $0.71 to $100,400.00.
What is the market capitalisation of YYAI?
YYAI has a market capitalisation of $5.17K on NASDAQ/NYSE.
What is the return on equity (ROE) of YYAI?
YYAI has a return on equity (ROE) of 13.81%. Its return on capital employed (ROCE) is 24.91%.
Is YYAI a good stock to buy?
This page provides a data-driven analysis of YYAI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.